No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
MESO240719C13000
- 0.28
- 0.000.00%
15min DelayClose Jul 1 15:54 ET
0.00High0.00Low
0.28Open0.28Pre Close0 Volume100 Open Interest13.00Strike Price0.00Turnover242.28%IV95.87%PremiumJul 19, 2024Expiry Date0.00Intrinsic Value100Multiplier18DDays to Expiry0.28Extrinsic Value100Contract SizeAmericanOptions Type0.1773Delta0.0708Gamma24.21Leverage Ratio-0.0261Theta0.0005Rho4.29Eff Leverage0.0039Vega
Intraday
- 5D
- Daily
News
Mesoblast Set To File BLA For Ryoncil With FDA Next Week
Mesoblast to Submit FDA Application for Ryoncil in Treating Pediatric GVHD
High Insider Ownership Growth Stocks On The ASX In June 2024
Cantor Fitzgerald Reiterates Overweight on Mesoblast
Mesoblast Analyst Ratings
Mesoblast Targets FDA Approval With Ryoncil